通过CTLA-4抑制靶向耗竭的细胞毒性T细胞可促进人骨髓纤维化异种移植物中肿瘤细胞的清除
研究探讨骨髓纤维化(MF)中细胞毒性T细胞耗竭及CTLA-4阻断的作用。MF患者细胞毒性T细胞抑制性受体CTLA-4表达增加、IFNγ和TNFα分泌减少,其配体CD80/CD86在粒细胞和单核细胞上增加。抗CTLA-4可恢复T细胞活化并促进肿瘤细胞清除,在患者来源异种移植物中CTLA-4阻断减少人髓系嵌合并导致脾和骨髓T细胞扩增。
要点
- MF患者细胞毒性T细胞CTLA-4表达增加且IFNγ、TNFα分泌减少。
- MF粒细胞和单核细胞CD80、CD86增加,可能抑制T细胞活化。
- 抗CTLA-4恢复MF患者T细胞活化并促进肿瘤细胞清除。
核心结论
- 这些发现揭示MF中T细胞功能障碍,并提示CTLA-4阻断可增强细胞毒性T细胞介导的抗肿瘤免疫应答。
研究设计与样本
- 研究分析MF患者细胞毒性T细胞的耗竭标志及髓系细胞对T细胞活化的影响,并在体外共培养体系及NSGS小鼠患者来源异种移植物中测试CTLA-4阻断。
- 患者来源异种移植物通过移植MF CD34+细胞并输注同源T细胞生成。
主要发现
- MF患者细胞毒性T细胞抑制性受体如CTLA-4表达增加,同时IFNγ和TNFα分泌减少。
- MF粒细胞和单核细胞上CTLA-4配体CD80和CD86增加。
- 与健康供者不同,MF患者细胞毒性T细胞在髓系细胞存在时活化减弱,单独培养或用抗CTLA-4处理时恢复。
- 在与细胞毒性T细胞共培养体系中,抗CTLA-4处理促进肿瘤性单核细胞和粒细胞清除。
- 在NSGS小鼠患者来源异种移植物中,CTLA-4阻断减少人髓系嵌合并导致脾和骨髓T细胞扩增。
临床怎么用
- 原文结论提示CTLA-4阻断可增强细胞毒性T细胞介导的抗肿瘤免疫应答,未据此给出临床推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myeloproliferative neoplasms represent a group of clonal hematopoietic disorders of which myelofibrosis (MF) is the most aggressive. In the context of myeloid neoplasms, there is a growing recognition of the dysregulation of immune response and T-cell function as significant contributors to disease progression and immune evasion. We investigated cytotoxic T-cell exhaustion in MF to restore immune response against malignant cells. Increased expression of inhibitory receptors like CTLA-4 was observed on cytotoxic T cells from MF patients together with a reduced secretion of IFNɣ and TNFɑ. CTLA-4 ligands CD80 and CD86 were increased on MF granulocytes and monocytes highlighting a possible role for myeloid cells in suppressing T-cell activation in MF patients. Unlike healthy donors, the activation of cytotoxic T cells from MF patients was attenuated in the presence of myeloid cells and restored when T cells were cultured alone or treated with anti-CTLA-4. Moreover, anti-CTLA-4 treatment promoted elimination of neoplastic monocytes and granulocytes in a co-culture system with cytotoxic T cells. To test CTLA-4 inhibition in vivo, patient-derived xenografts were generated by transplanting MF CD34+ cells and by infusing homologous T cells in NSGS mice. CTLA-4 blockade reduced human myeloid chimerism and led to T-cell expansion in spleen and bone marrow. Overall, these findings shed light on T-cell dysfunction in MF and suggest that CTLA-4 blockade can boost the cytotoxic T cell-mediated immune response against tumor cells.
引用
- Tavernari L, Rontauroli S, Norfo R, et al. Targeting exhausted cytotoxic T cells through CTLA-4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts. Am J Hematol. 2024. PMID: 38953347. doi:10.1002/ajh.27428
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。